(Q44517611)

English

Prophylactic treatment with melatonin after status epilepticus: effects on epileptogenesis, neuronal damage, and behavioral changes in a kainate model of temporal lobe epilepsy

scientific article published on 28 February 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Prophylactic treatment with melatonin after status epilepticus: effects on epileptogenesis, neuronal damage, and behavioral changes in a kainate model of temporal lobe epilepsy (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

0 references

status epilepticus

1 reference

based on heuristic

inferred from title

behavioural change

1 reference

based on heuristic

inferred from title

Dimitrina Atanasova

8

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

author name string

Jana Tchekalarova

1

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Zlatina Petkova

2

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Daniela Pechlivanova

3

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Slavianka Moyanova

4

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Lidia Kortenska

5

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Rumiana Mitreva

6

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Valentin Lozanov

7

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Nikolai Lazarov

9

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Alexander Stoynev

10

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

publication date

28 February 2013

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Epilepsy Behavior

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

27

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

174-187

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Pineal Melatonin: Cell Biology of Its Synthesis and of Its Physiological Interactions*

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.01.009

7 January 2021

Melatonin in experimental seizures and epilepsy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.01.009

7 January 2021

The effects of the intraamygdalar melatonin injections on the anxiety like behavior and the spatial memory performance in male Wistar rats

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.01.009

7 January 2021

Effect of melatonin and vitamin E on diabetes-induced learning and memory impairment in rats

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.01.009

7 January 2021

Sustained activation of Akt by melatonin contributes to the protection against kainic acid-induced neuronal death in hippocampus

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.01.009

7 January 2021

Protection against cognitive deficits and markers of neurodegeneration by long-term oral administration of melatonin in a transgenic model of Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.01.009

7 January 2021

Chronic melatonin treatment and its precursor L-tryptophan improve the monoaminergic neurotransmission and related behavior in the aged rat brain

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.01.009

7 January 2021

Excitotoxicity, oxidative stress, and the neuroprotective potential of melatonin

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.01.009

7 January 2021

Melatonin response in active epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.01.009

7 January 2021

Utility of high doses of melatonin as adjunctive anticonvulsant therapy in a child with severe myoclonic epilepsy: two years' experience

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.01.009

7 January 2021

Patients with intractable epilepsy have low melatonin, which increases following seizures

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.01.009

7 January 2021

Anticonvulsant activity of melatonin against seizures induced by quinolinate, kainate, glutamate, NMDA, and pentylenetetrazole in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.01.009

7 January 2021

Melatonin attenuates L-cysteine-induced seizures and lipid peroxidation in the brain of mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.01.009

7 January 2021

Circadian effects of beta-endorphin, melatonin, DSIP, and amphetamine on pentylenetetrazol-induced seizures.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.01.009

7 January 2021

Influence of melatonin upon the protective action of conventional anti-epileptic drugs against maximal electroshock in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.01.009

7 January 2021

The anticonvulsant properties of melatonin on kindled seizures in rats.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.01.009

7 January 2021

Anticonvulsant effects of melatonin in amygdala-kindled rats

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.01.009

7 January 2021

Melatonin attenuates kainic acid-induced hippocampal neurodegeneration and oxidative stress through microglial inhibition

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.01.009

7 January 2021

Effects of pinealectomy and the treatment with melatonin on the temporal lobe epilepsy in rats

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.01.009

7 January 2021

Neuroprotection by melatonin from kainate-induced excitotoxicity in rats

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.01.009

7 January 2021

The psychiatric comorbidity of epilepsy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.01.009

7 January 2021

Diurnal variation in pilocarpine-induced generalized tonic-clonic seizure activity

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.01.009

7 January 2021

Diurnal rhythms of spontaneous recurrent seizures and behavioral alterations of Wistar and spontaneously hypertensive rats in the kainate model of epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.01.009

7 January 2021

Diurnal variations in depression-like behavior of Wistar and spontaneously hypertensive rats in the kainate model of temporal lobe epilepsy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.01.009

7 January 2021

IGF-I ameliorates hippocampal neurodegeneration and protects against cognitive deficits in an animal model of temporal lobe epilepsy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.01.009

7 January 2021

Age-dependent cognitive and behavioral deficits after kainic acid seizures.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.01.009

7 January 2021

Electrographic, clinical and pathological alterations following systemic administration of kainic acid, bicuculline or pentetrazole: Metabolic mapping using the deoxyglucose method with special reference to the pathology of epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.01.009

7 January 2021

The effect of variations in pH and temperature on stability of melatonin in aqueous solution

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.01.009

7 January 2021

Recurrent spontaneous motor seizures after repeated low-dose systemic treatment with kainate: assessment of a rat model of temporal lobe epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.01.009

7 January 2021

Modification of seizure activity by electrical stimulation. II. Motor seizure

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.01.009

7 January 2021

Immobility induced by forced swimming in rats: Effects of agents which modify central catecholamine and serotonin activity

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.01.009

7 January 2021

The ontogeny of seizures in a rat model of limbic epilepsy: evidence for a kindling process in the development of chronic spontaneous seizures

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.01.009

7 January 2021

The course of untreated seizures in the pilocarpine model of epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.01.009

7 January 2021

Melatonin: both master clock output and internal time-giver in the circadian clocks network

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.01.009

7 January 2021

Temporal lobe seizures alter the amplitude and timing of rat behavioral rhythms

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.01.009

7 January 2021

Cyclicity of spontaneous recurrent seizures in pilocarpine model of temporal lobe epilepsy in rat

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.01.009

7 January 2021

Seizures in the intrahippocampal kainic acid epilepsy model: characterization using long-term video-EEG monitoring in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.01.009

7 January 2021

Attenuating effects of melatonin on pilocarpine-induced seizures in rats

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.01.009

7 January 2021

Effects of melatonin and agomelatine in anxiety-related procedures in rats: interaction with diazepam

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.01.009

7 January 2021

Elevated plasma corticosterone level and depressive behavior in experimental temporal lobe epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.01.009

7 January 2021

Depression after status epilepticus: behavioural and biochemical deficits and effects of fluoxetine

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.01.009

7 January 2021

Elevated anxiety and depressive-like behavior in a rat model of genetic generalized epilepsy suggesting common causation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.01.009

7 January 2021

Different emotional disturbances in two experimental models of temporal lobe epilepsy in rats

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.01.009

7 January 2021

Sex differences in forced-swim and open-field test behaviours after chronic administration of melatonin.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.01.009

7 January 2021

Corticosterone attenuates the antidepressant-like effects elicited by melatonin in the forced swim test in both male and female rats

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.01.009

7 January 2021

Melatonin affects the immobility time of rats in the forced swim test: the role of serotonin neurotransmission

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.01.009

7 January 2021

Role of 5-HT in stress, anxiety, and depression.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.01.009

7 January 2021

A noradrenergic and serotonergic hypothesis of the linkage between epilepsy and affective disorders

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.01.009

7 January 2021

Absence of discontinuation symptoms with agomelatine and occurrence of discontinuation symptoms with paroxetine: a randomized, double-blind, placebo-controlled discontinuation study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.01.009

7 January 2021

Novel melatonin-based therapies: potential advances in the treatment of major depression

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.01.009

7 January 2021

Pharmacological effects of melatonin treatment on both locomotor activity and brain serotonin release in rats

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.01.009

7 January 2021

Melatonin modulates [3h]serotonin release in the rat hippocampus: effects of circadian rhythm

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.01.009

7 January 2021

Which clinical and experimental data link temporal lobe epilepsy with depression?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.01.009

7 January 2021

A 5-month period of epilepsy impairs spatial memory, decreases anxiety, but spares object recognition in the lithium-pilocarpine model in adult rats

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.01.009

7 January 2021

Differential impairments of spatial memory and social behavior in two models of limbic epilepsy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.01.009

7 January 2021

What are the differences between long-term, short-term, and working memory?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.01.009

7 January 2021

Treatment with valproate after status epilepticus: effect on neuronal damage, epileptogenesis, and behavioral alterations in rats

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.01.009

7 January 2021

Impaired spatial working memory but spared spatial reference memory following functional loss of NMDA receptors in the dentate gyrus

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.01.009

7 January 2021

Effects of chronic administration of melatonin on spatial learning ability and long-term potentiation in lead-exposed and control rats.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.01.009

7 January 2021

Melatonin administration impairs visuo-spatial performance and inhibits neocortical long-term potentiation in rats

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.01.009

7 January 2021

Identifiers

10.1016/J.YEBEH.2013.01.009

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44517611&oldid=2026605597"